Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 7/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.53 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | IGF1R | P08069 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9445874 | 0.81 | RAB9A (0.60) | RAB9ATDP1MAPTKDM4ENPC1 | |
| SCHEMBL9445878 | 0.81 | RAB9A (0.60) | RAB9ATDP1MAPTKDM4ENPC1 | |
| SCHEMBL10906195 | 0.77 | RAB9A (0.55) | RAB9ATDP1MAPTKDM4ENPC1 | |
| SCHEMBL21891546 | 0.77 | RAB9A (0.51) | RAB9ATDP1MAPTKDM4ENPC1 | |
| SCHEMBL16646924 | 0.75 | RAB9A (0.54) | RAB9ATDP1MAPTKDM4ENPC1 | |
| SCHEMBL25670655 | 0.75 | MCL1 (0.58) | RAB9ATDP1MAPTKDM4ENPC1 | |
| SCHEMBL18164148 | 0.75 | RAB9A (0.54) | RAB9ATDP1MAPTKDM4ENPC1 | |
| SCHEMBL11562835 | 0.74 | RAB9A (0.53) | RAB9ATDP1MAPTKDM4ENPC1 | |
| SCHEMBL25415051 | 0.74 | TDP1 (0.67) | RAB9ATDP1MAPTKDM4ENPC1 | |
| SCHEMBL17030776 | 0.73 | KMT2A (0.54) | RAB9ATDP1MAPTKDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113717076-B | Preparation method for obtaining methane functional product based on iron/light combined catalysis | 大连理工大学 | 2022-08-02 | — | — | CN | claimed |
| CN-107417859-A | A kind of high melt strength, propylene and preparation method of heteroaromatic ring derivative grafting | 中国石油化工股份有限公司 | 2017-12-01 | — | — | CN | claimed |
| CN-113717076-B | Preparation method for obtaining methane functional product based on iron/light combined catalysis | 大连理工大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-113717076-A | Preparation method for obtaining methane functional product based on iron/light combined catalysis | 大连理工大学 | 2021-11-30 | — | — | CN | disclosed |
| CN-107417859-B | High-melt-strength polypropylene grafted by heteroaromatic ring derivative and preparation method thereof | 中国石油化工股份有限公司 | 2021-02-26 | — | — | CN | disclosed |
| US-10377711-B2 | Cannabinoid type 1 receptor modulators | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2019-08-13 | — | — | US | disclosed |
| US-20180118681-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2018-05-03 | — | — | US | disclosed |
| CN-107417859-A | A kind of high melt strength, propylene and preparation method of heteroaromatic ring derivative grafting | 中国石油化工股份有限公司 | 2017-12-01 | — | — | CN | disclosed |
| EP-3186225-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | The Governing Council of the University of Toronto (CA) | 2017-07-05 | — | — | EP | disclosed |
| WO-2016029310-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2016-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118681-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | CNR1, CNR2, GPR18 | RAB9A 1328/4885TDP1 3599/4885MAPT 2186/4885 |
| US-10377711-B2 | Cannabinoid type 1 receptor modulators | CNR1, CNR2, GPR18 | RAB9A 1328/4885TDP1 3599/4885MAPT 2186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.